Endo International | Lucro Operacional



Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Amarin USD -1.7M 8.47M 2025-09
ANI Pharmaceuticals USD 22.83M 7.66M 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Eli Lilly USD 8.99B 599.9M 2025-12
Heron Therapeutics USD -5.66M 782K 2024-09
Hikma Pharmaceutical USD 187M 95M 2025-06
Ligand Pharmaceuticals USD 158.89M 149.17M 2025-09
Merck USD 6.24B 318M 2025-12
Novartis USD 4.5B 363M 2025-09
Pacira USD 13.15M 2.92M 2025-09
Perrigo USD 93.4M 37.8M 2025-09
Pfizer USD 4.65B 3.99B 2025-12
Phibro Animal Health USD 25.53M 7.83M 2024-12
Supernus Pharmaceuticals USD -60.18M 72.32M 2025-09
Takeda JPY 168.82B 479.89B 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09
Zoetis USD 835M 101M 2025-12


Endo International Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.